A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Public ClinicalTrials.gov record NCT04882098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants With Active Psoriatic Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
Study identification
- NCT ID
- NCT04882098
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,054 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2021
- Primary completion
- Dec 29, 2024
- Completion
- Oct 5, 2027
- Last update posted
- Aug 27, 2026
2021 – 2027
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates | Birmingham | Alabama | 35205 | — |
| Arizona Arthritis and Rheumatology Research PLLC | Flagstaff | Arizona | 86001-6218 | — |
| Arizona Arthritis & Rheumatology Associates PC | Glendale | Arizona | 85306 | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Tucson | Arizona | 85704 | — |
| Advanced Medical Research | La Palma | California | 90624 | — |
| Rheumatology Center of San Diego | San Diego | California | 92128 | — |
| Medvin Clinical Research, Inc. | Whittier | California | 90606 | — |
| Heuer M.D. Research | Orlando | Florida | 32819 | — |
| The Arthritis Center, Inc. | Palm Harbor | Florida | 34684 | — |
| Forcare Clinical Research Inc | Tampa | Florida | 33624 | — |
| Klein And Associates M D P A | Hagerstown | Maryland | 21740 | — |
| Advanced Rheumatology | Okemos | Michigan | 48864 | — |
| Arthritis Consultants | St Louis | Missouri | 63141 | — |
| Glacier View Research Institute | Kalispell | Montana | 59901-3158 | — |
| NYU Langone Ambulatory Care Brooklyn Heights | Brooklyn | New York | 11201 | — |
| PMG Research of Salisbury | Salisbury | North Carolina | 28144 | — |
| STAT Research, Inc. | Springboro | Ohio | 45342 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Dr. Ramesh Gupta | Memphis | Tennessee | 38119 | — |
| Austin Regional Clinic | Austin | Texas | 78731 | — |
| Adriana Pop Moody MD Clinic PA | Corpus Christi | Texas | 78404 | — |
| Southwest Rheumatology Research LLC | Mesquite | Texas | 75150 | — |
| Arthritis And Osteoporosis Clinic | Waco | Texas | 76710 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 257 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04882098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04882098 live on ClinicalTrials.gov.